Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccinePericarditis tras la administración de la vacuna de ARNm BNT162b2 contra la COVID-19
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA a follow-up surveillance study.